Next Article in Journal
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses
Next Article in Special Issue
Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression
Previous Article in Journal
T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
Previous Article in Special Issue
Monitoring of the Immune Dysfunction in Cancer Patients
Article Menu

Export Article

Open AccessReview
Vaccines 2016, 4(3), 31;

Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy

Department of Microbiology Immunology, University of Miami, Miami, FL 33146, USA
Author to whom correspondence should be addressed.
Academic Editor: Theresa L. Whiteside
Received: 14 July 2016 / Revised: 2 September 2016 / Accepted: 7 September 2016 / Published: 9 September 2016
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)
Full-Text   |   PDF [697 KB, uploaded 9 September 2016]   |  


Neutrophils are the most abundant circulating blood cell type in humans, and are the first white blood cells recruited at the inflammation site where they orchestrate the initial immune response. Although their presence at the tumor site was recognized in the 1970s, until recently these cells have been neglected and considered to play just a neutral role in tumor progression. Indeed, in recent years neutrophils have been recognized to play a dual role in tumor development by either assisting the growth, angiogenesis, invasion, and metastasis or by exerting tumoricidal action directly via the secretion of antitumoral compounds, or indirectly via the orchestration of antitumor immunity. Understanding the biology of these cells and influencing their polarization in the tumor micro- and macro-environment may be the key for the development of new therapeutic strategies, which may finally hold the promise of an effective immunotherapy for cancer. View Full-Text
Keywords: gMDSC; neutrophils; cancer; immunotherapy; sex gMDSC; neutrophils; cancer; immunotherapy; sex

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zilio, S.; Serafini, P. Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy. Vaccines 2016, 4, 31.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top